These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
96 related items for PubMed ID: 9345312
1. Neuropeptide Y enhances ATP-induced formation of inositol phosphates in chromaffin cells. Zheng J, Zhang P, Toews M, Hexum TD. Biochem Biophys Res Commun; 1997 Oct 09; 239(1):287-90. PubMed ID: 9345312 [Abstract] [Full Text] [Related]
2. Neuropeptide Y receptor-mediated sensitization of ATP-stimulated inositol phosphate formation. Drakulich DA, Walls AM, Toews ML, Hexum TD. J Pharmacol Exp Ther; 2003 Nov 09; 307(2):559-65. PubMed ID: 12970392 [Abstract] [Full Text] [Related]
3. Betagamma subunits mediate the NPY enhancement of ATP-stimulated inositol phosphate formation. Li X, Ikezu T, Hexum TD. Peptides; 2004 Feb 09; 25(2):267-74. PubMed ID: 15063008 [Abstract] [Full Text] [Related]
7. Neuropeptide Y inhibits chromaffin cell nicotinic receptor-stimulated tyrosine hydroxylase activity through a receptor-linked G protein-mediated process. Zheng J, Zhang P, Hexum TD. Mol Pharmacol; 1997 Dec 09; 52(6):1027-33. PubMed ID: 9415712 [Abstract] [Full Text] [Related]
8. Synergy between the inositol phosphate responses to transfected human adenosine A1-receptors and constitutive P2-purinoceptors in CHO-K1 cells. Megson AC, Dickenson JM, Townsend-Nicholson A, Hill SJ. Br J Pharmacol; 1995 Aug 09; 115(8):1415-24. PubMed ID: 8564200 [Abstract] [Full Text] [Related]
9. Neuropeptide Y Y2 receptor and somatostatin sst2 receptor coupling to mobilization of intracellular calcium in SH-SY5Y human neuroblastoma cells. Connor M, Yeo A, Henderson G. Br J Pharmacol; 1997 Feb 09; 120(3):455-63. PubMed ID: 9031749 [Abstract] [Full Text] [Related]
10. Intracellular signaling mechanisms mediating catecholamine release upon activation of NPY Y1 receptors in mouse chromaffin cells. Rosmaninho-Salgado J, Araújo IM, Alvaro AR, Duarte EP, Cavadas C. J Neurochem; 2007 Nov 09; 103(3):896-903. PubMed ID: 17868303 [Abstract] [Full Text] [Related]
12. Use of D-myo inositol 1,2,6 trisphosphate to inhibit contractile activity in rat ventricular cardiomyocytes induced by neuropeptide Y and other cardioactive peptides through phospholipase C. Bell D, Millar BC, McDermott BJ. Br J Pharmacol; 1997 Dec 09; 122(8):1655-60. PubMed ID: 9422811 [Abstract] [Full Text] [Related]
13. NPY and carbachol raise Ca2+ in SK-N-MC cells by three different mechanisms. Evidence for inositol phosphate-independent Ca2+ mobilization by NPY. Michel MC, Feth F, Stieneker M, Rascher W. Naunyn Schmiedebergs Arch Pharmacol; 1992 Apr 09; 345(4):370-4. PubMed ID: 1620239 [Abstract] [Full Text] [Related]
14. Comparative aspects of the role of neuropeptide Y in the regulation of the vertebrate heart. Xiang H. Cardioscience; 1994 Dec 09; 5(4):209-13. PubMed ID: 7742479 [Abstract] [Full Text] [Related]
15. Neuropeptide Y binding and inhibition of cAMP accumulation in human neuroepithelioma cells. Lobaugh LA, Blackshear PJ. Am J Physiol; 1990 May 09; 258(5 Pt 1):C913-22. PubMed ID: 2159234 [Abstract] [Full Text] [Related]
16. Selective stimulation of catecholamine release from bovine adrenal chromaffin cells by an ionotropic purinergic receptor sensitive to 2-methylthio ATP. Tomé AR, Castro E, Santos RM, Rosário LM. BMC Neurosci; 2007 Jun 20; 8():41. PubMed ID: 17584495 [Abstract] [Full Text] [Related]